Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain

Overview of attention for article published in HEPAC Health Economics in Prevention and Care, March 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 2 policy sources

Citations

dimensions_citation: 73 Dimensions

Readers on

mendeley: 92 Mendeley
connotea: 1 Connotea

Summary Policy documents Dimensions citations

So far, Altmetric has seen 5 policy documents that reference this research output.

Chronic obstructive pulmonary disease in over 16s: diagnosis and management : Full guideline

Cited by National Institute for Health and Care Excellence on 17 Jul 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Chronic obstructive pulmonary disease in over 16s: diagnosis and management : H: Economic model report

Cited by National Institute for Health and Care Excellence on 05 Dec 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Chronic obstructive pulmonary disease in over 16s: diagnosis and management: June 2010: full guideline

Cited by National Institute for Health and Care Excellence on 05 Dec 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Triple Therapy for Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Cited by Canadian Agency for Drugs and Technologies in Health on 05 Aug 2010

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity, including 1 additional policy documents.